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Abstract
Camphorataimide B (CamB) has anticancer activities against several tumors. Here, we aimed to investigate the
mechanism(s) by which CamB inhibits metastasis of colorectal cancer (CRC) cells. Low-dose CamB did not affect the cell
viability and cell cycle progression of CRC cells, but signiﬁcantly inhibited the metastatic potentials of CRC cells.
Mechanically, CamB reduced the protein and mRNA expression of BMP4, and inhibited Smad and FAK/Src/Akt
signaling. CamB also decreased Snail levels by promoting its degradation via proteasome and thereafter reduced Snailmediated BMP4 transcription. Moreover, CamB considerably inhibited the in vivo metastasis of DLD-1 cells in xenograft
mice.
Keywords: Bone morphogenetic protein 4, Camphorataimide-B, Colorectal cancer, FAK, Snail

1. Introduction

C

olorectal cancer (CRC) is a leading lifethreatening malignancy worldwide, and the
morbidity and mortality of CRC have increased in
the past decade [1]. CRC originates from dysplastic
adenomatous polyps and gradually transforms into

invasive carcinoma because of genetic modiﬁcations
that reinforce colorectal epithelial cell growth and
suppress colorectal epithelial cell apoptosis [2].
Today, the combination of chemotherapy and surgery has been widely used in patients with CRC;
however, the high recurrence and distant metastasis
of CRC cells still lead to the poor survival of patients
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with CRC with late-stage progression [1]. Cell
adhesion, cell motility, and invasive capability play
a central role in CRC metastasis [3]. Therefore, the
inhibition of CRC metastasis has been recognized as
a promising approach to improve CRC treatments
and increase the survival rate of patients with CRC.
The identiﬁcation of phytochemicals with anticancer activity has been an important strategy to
develop novel therapeutic adjuvants for cancer
treatments and even novel anticancer drugs. Over
time, some natural compounds have been demonstrated to have in vitro or in vivo chemopreventive
and anticancer activities [4e6]. Antrodia camphorata
is a medicinal fungus (Ganoderma species) of the
Polyporaceae family that commonly grows in
camphor tree in Taiwan. In the past two decades,
the various biological functions of A. camphorata
mycelium, including anti-inﬂammatory, anti-oxidative, and anticancer activities, have been reported
[7]. Camphorataimide B (CamB), a derivative isolated from A. camphorata mycelium, has been reported to have anticancer effect against breast
cancer cells [8].
Here, we aimed to explored the anti-metastatic
effects of CamB on CRC cells and the underlying
mechanism. Metastatic potentials were evaluated by
using transmigration, invasion assays, and xenograft
mouse model. Molecular mechanisms were
demonstrated using Western blot, quantitative realtime polymerase chain reaction (qPCR), chromatin
immunoprecipitation, and reporter assay. Our
ﬁndings reveal that CamB can inhibit the metastatic
potentials of CRC cells through the suppression of
the Smad/FAK/Akt axis and the promoted degradation of Snail/bone morphogenetic protein 4
(BMP4) complex via promoting ubiquitin-mediated
proteasome degradation.

2. Materials and methods
2.1. Chemicals, reagents, and antibodies
CamB was synthesized from succinic anhydride as
previously described (Cheng et al., 2008). Crystal
violet, 2-propanol, 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT), 1-butanol,
dimethyl sulfoxide (DMSO), phosphate-buffered
saline (PBS), sodium chloride, sodium dodecyl sulfate (SDS), Tris-HCl, type I collagen, and trypsin/
EDTA were purchased from Sigma-Aldrich. Antibodies against BMP4, a-actinin, Smad1/5/9, Smad4,
Lamin A/C, talin, tensin 2, a-actinin, vinculin, focal
adhesion kinase (FAK), phospho-FAK (pY397-FAK),
Src, phospho-Src (pY416-Src), p130Cas, AKT,
phospho-AKT (pS473-AKT), RhoA, GTP-RhoA,

Cdc42, GTP-Cdc42, Rac1, GTP-Rac1, paxillin,
phospho-paxillin (pY31-Paxillin, pY118-Paxillin,
pY181-Paxillin), Snail, b-actin, and tubulin, as well
as peroxidase-conjugated antibodies against mouse
or rabbit IgG, were obtained from Santa Cruz
Biotechnology, Inc. or Abcam.
2.2. Cell culture
Human colon cancer lines DLD-1, SW480, and
SW620 were purchased from BCRC (Hsinchu,
Taiwan), cultured in RPMI-1640 and L-15 mediums
supplemented with 10% fetal bovine serum (FBS;
Biological Industries, Cromwell, CT, USA), and
incubated at 37  C with 5% CO2. The cells were
cultured until 80% conﬂuency and then incubated
with the indicated concentrations of CamB for 24 h.
The treated cells were harvested, washed with PBS,
and then used for subsequent analyses. DMSO
(0.1%) treatment was used as the control (Ctrl, or
0 mM).
2.3. Cell viability assay
Cell viability was determined using MTT assay as
previously described [9]. Brieﬂy, the cells were
treated with CamB at serial concentrations for
indicated times, and then incubated with MTT solution. After adding isopropanol to solubilize the
formed formazan, the absorbance of the solution at
563 nm was measured using a spectrophotometer.
The percentage of viable cells was estimated by
comparing with control.
2.4. Cell cycle distribution and cellular apoptosis
analyses
Cell cycle distribution and cellular apoptosis were
determined by ﬂow cytometry. The cells were synchronized at G0 by 16-h serum-free starvation, then
incubated with the indicated concentrations of
CamB for 24 h, trypsinized for detachment, and
collected by centrifugation. The collected cells were
ﬁxed with 70% ethanol, washed with PBS, incubated
with propidium iodide (PI) alone (cell cycle distribution) or with PI and Annexin V (cellular
apoptosis) in the dark for 30 min, and then analyzed
using a ﬂow cytometer equipped with CellQuest Pro
software.
2.5. Cell migration and invasion assays
Cells were pretreated with CamB for 24 h, harvested by trypsinization, and then seeded on 24-well
cell culture inserts (8 mm pore size, Millipore). FBS

(20%) placed in the lower compartment of the plate
was used as the chemoattractant. After 12 h of incubation, the cells that migrated to the lower surface
of the insert were ﬁxed with paraformaldehyde and
stained with Giemsa reagent (Sigma-Aldrich). The
stained cells were photographed, and the total cell
number from ﬁve random ﬁelds was counted using
light microscopy. For the invasion assay, 100 mL of
Matrigel (20  dilution in PBS) was added into the
culture inserts and then air-dried prior to cell
seeding as described above.
2.6. Cell adhesion assay
Cells were incubated with the indicated concentrations of CamB for 24 h, transferred into 12-well
Matrigel-coated plates at 105 cells/well, and then
incubated at 37  C for 16 h. After incubation, nonadherent cells were removed by washing with PBS,
and the attached cells were photographed and
quantitated.
2.7. Clonogenic assay
Cells were suspended in agarose medium containing 0.3% agarose, 10% FBS, and the indicated
concentrations of CamB; seeded onto a 6-well plate,
which was pre-coated with a layer of solidiﬁed 0.6%
agarose; and then incubated at 37  C for 1 week. At
the end of incubation, the cell colonies were ﬁxed
with methanol/acetic acid (3:1), stained with crystal
violet, ant then photographed using a Nikon Eclipse
TE2000-U microscope equipped with a Nikon
DXM1200 digital camera. The colonies with size
0.1 mm were counted for quantitation.
2.8. Immunoﬂuorescence staining
Cells were ﬁxed by 4% ice-cold formaldehyde,
reacted with blocking buffer containing 0.5% Triton
X-100 for 1 h at 25  C, and incubated with primary
antibodies for 16 h at 4  C. The cells were washed
with PBS, and the bound primary antibodies were
detected using Alexa Fluor-labeled secondary antibody (Jackson ImmunoResearch Laboratories, West
Grove, PA, USA). Alexa Fluor-conjugated phalloidin
(Cell Signaling) was used for the detection of polymerized F-actin microﬁlaments. Fluorescence image
was acquired using a laser scanning confocal microscope system (Zeiss 510-Meta, Zeiss, Oberkochen, Germany).
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2.9. Western blot and small GTPase activity
assessment
Western blot was conducted as previously
described [10]. Brieﬂy, cells were lysed in Tris lysis
buffer containing protease and phosphatase inhibitor cocktail (Sigma-Aldrich). Then, the resulting
crude proteins were separated by SDS-polyacrylamide gel electrophoresis, transferred to polyvinylidene diﬂuoride membrane (Immobilon,
Merck), and then reacted with the primary antibodies following with the secondary antibodies. The
bound antibodies was detected using enhanced
chemiluminescence reagent (SuperSignal West
Dura HRP Detection Kit; Pierce Biotechnology,
Rockford, IL, USA) an image analysis system (Fujiﬁlm, Tokyo, Japan).
Small GTPase activity was assessed by GTPase
afﬁnity precipitation as previously described [11].
Brieﬂy, cells were lysed in MLB buffer (Millipore,
Bedford, MA, USA), and the resulting crude protein
were reacted with Rac/Cdc42-binding domain and
Rho protein-binding domain agarose conjugate
beads. The reacted beads were collected and
washed with MLB buffer, and the bound proteins
were acquired by boiling the beads with SDS sample buffer and analyzed by Western blot.
2.10. Co-immunoprecipitation assay
Cells were lysed with RIPA buffer containing
protease and phosphatase inhibitor cocktail for
crude protein extraction. The extracted proteins
were pre-cleared with 50 mL of a 50% slurry of
protein G-Sepharose beads 4B (GE Healthcare) for
60 min at 4  C and then incubated with 2 mg of
primary antibody or nonspeciﬁc IgG (negative
control) for 16 h at 4  C. The proteineantibody
complex was collected using recombinant protein
G-Sepharose 4B beads and subjected to Western
blot analysis.
2.11. RT-PCR and qPCR
Gene expression was assessed by RT-PCR and
qPCR as previously described [4]. Brieﬂy, total RNA
was isolated from individual samples using TRIzol
reagent (Invitrogen, Carlsbad, CA, USA). The puriﬁed RNA was used as a template to generate ﬁrststrand cDNA using a GoScript reverse transcription
kit (Promega, Madison, WI, USA).
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2.12. Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation analysis was
performed as previously described [12]. The puriﬁed, immunoprecipitated DNA was analyzed by
RT-PCR and visualized by ethidium bromide
staining after gel electrophoresis.
2.13. Reporter assay for transcriptional activity
Cells were transfected with BMP4 promoterluciferase vectors using Tuberfast transfection reagents for 24 h and then incubated with CamB (10,
20, or 30 mM) for 24 h. The treated cells were washed
with PBS and lysed with 50 mL of passive lysis
buffer. The resulting lysates were transferred to 96well plates and incubated with luciferin substrate.
Luciferase activity and b-gal enzyme activity were
determined using a luciferase assay kit and a
microplate reader, respectively, according to the
manufacturer's instructions. Relative luciferase activity was presented as the ratio of the ﬂuorescence
units of BMP4 reporter plasmid-transfected cells to
the ﬂuorescence units of pGL3-Basic-transfected
cells.
2.14. Transient Snail overexpression
DLD-1 cells were seeded at 2  105 cells/mL in
complete medium, cultured until 90% conﬂuency,
and transfected with control vector pcDNA3.1 or
pCMV-Tag2B-Snail (a gift from Dr. Li-Sung Hsu,
Institute of Medicine, Chung Shan Medical University) using T-Pro non-liposomal transfection reagent (T-Pro Biotechnology, Taipei City, Taiwan)
according to the manufacturer's instruction for Snail
overexpression.
2.15. Xenograft mouse model
Four-week-old male Balb/c nude mice were obtained from the National Laboratory Animal Center
of Taiwan (Taipei City, Taiwan) and maintained
under the supervision of the Institutional Animal
Care and Use Committee at Chung Shan Medical
University. All animal experiments were performed
under speciﬁc pathogen-free conditions in accordance with the approved protocol and institutional
guidelines. The metastatic human colon cancer cell
line DLD-1 was transduced with a lentivirus
expressing ﬁreﬂy luciferase to produce luciferaseexpressing DLD-1 (Luc-DLD-1). Luc-DLD-1 cells
(2  106) were injected into the peritoneum of nude
mice by surgical procedure for the assessment of
abdominal. In parallel, Luc-DLD-1 cells were also

injected into the spleen of nude mice for the speciﬁc
assessment of liver metastases as previously
described [13]. The mice were randomly divided
into four groups (5 mice/group) on day 6 after the
injection of Luc-DLD-1 and orally administrated
with 10 or 20 mg/kg CamB every 3 days for 35 days
for the metastasis assessments. The mice for in vivo
tumor growth assessment were anesthetized and
received an intraperitoneal injection of luciferin
(150 mg/kg body weight prepared in PBS). The
resulting bioluminescence images were captured
using an IVIS-200 imaging system (Xenogen,
Alameda, CA, USA) and processed using Living
Image software (Xenogen) through the region-ofinterest analysis of the total photons per second. At
the end of image acquirement, the mice were
sacriﬁced to evaluate the metastasis of cancer cells
by determining organ weights and immunohistochemical (IHC) staining.
2.16. Histopathological examination and IHC
staining
The tissues were collected, cut into small pieces,
ﬁxed with 10% buffered neutral formaldehyde, and
embedded in parafﬁn. Then, the embedded tissues
were cut into sections with a thickness of 3e5 mm.
The sections for histopathological examination were
stained with hematoxylin and eosin (H&E). Histopathological properties were examined by light
microscopy at 400  magniﬁcation. The sections for
IHC staining were blocked with BSA, reacted with
antibodies against human BMP4 and Snail, and
washed with PBS. The washed sections were incubated with HRP-conjugated anti-IgG antibodies and
reacted with the substrateechromogen reagent.
Images were acquired through a charge-coupled
device camera and analyzed using an image analysis system (Fujiﬁlm).
2.17. Statistical analysis
The data from three independent experiments
were presented as the mean ± standard deviation
(SD) except where indicated. Student's t-test was
used to analyze the signiﬁcance of difference. Results with p < 0.05 were considered statistically
signiﬁcant.

3. Results
3.1. Effects of CamB on human CRC cells
The structure of CamB is shown in Fig. 1A. The
effects of CamB on the cell viability and morphology
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Fig. 1. Effects of CamB on cell viability, cell morphology, cell cycle progression, and cellular apoptosis of CRC cells. (A) Chemical structure of
CamB and cell viability of DLD-1, SW480, and SW620 cells treated with serial concentrations (0e100 mM) of CamB for 24 h. (B) H&E staining for
monitoring the cell morphology of CRC cells treated with CamB for 24 h. (C) Cell cycle distribution analysis by PI staining and ﬂow cytometry. (D)
Cell apoptosis analysis of cells treated with indicated CamB concentrations for 24 h using PI/Annexin V staining and ﬂow cytometry. Quantitative
results are presented as mean ± SD. * and **, p < 0.01 and p < 0.001 compared with control, respectively.

of human CRC cell lines DLD-1, SW480, and SW620
were ﬁrst explored. As shown in Fig. 1A, the cell
viability of these cells was reduced by high-doses
CamB (50e100 mM), but not affected by low-doses
CamB (30 mM) compared with DMSO control.
Next, we focused on the anti-tumorigenic activity of
low-doses CamB (10e30 mM). Low-doses CamB
neither inﬂuenced the cell morphology and cell
cycle progression nor induced the cellular apoptosis
of tested CRC cells (Fig. 1BeD).
3.2. CamB attenuates migration and invasion of
CRC cells and downregulates cellular F-actin
expression
Next, we explored the effects of CamB on metastatic potentials of CRC cells. As shown in Fig. 2A,
the low-doses CamB (20 and 30 mM) signiﬁcantly
attenuated the migration and invasion of the tested
CRC cells (p < 0.05 compared with control). In
addition, the low-doses CamB also reduced the cell
adhesion and colony formation ability of the tested
CRC cells (Fig. 2B and C, for 20 and 30 mM, p < 0.05
compared with control). Then, we examined the
effects of CamB on the cytoskeleton organization
that was closely related to cell adhesion and cell
motility. The results showed that 30 mM CamB disrupted normal cytoskeletal actin organization
compared with control (Fig. 2D). Together, these

ﬁndings reveal that low-doses CamB can reduce the
metastatic potentials of CRC cells.
3.3. Downregulated BMP4 expression and Samd/
FAK signaling are associated with the inhibited
metastatic potentials of CRC cells in response to
CamB
Multiple mediators produced by cancer cells are
involved in the metastatic dissemination of tumors.
Therefore, we investigated whether CamB alters the
production of metastasis-associated mediators by
CRC cells. By cytokine array analysis, we observed
that the production of angiogenin, CXCL13/B
lymphocyte chemoattractant, BMP4, ciliary neurotrophic factor, CCL11/eotaxin-3, and insulin-like
growth factor binding protein 2 by DLD-1 cells were
signiﬁcantly decreased in response to CamB treatment (p < 0.05 compared with control, Fig. 3A and
B). On the contrary, CamB increased the production
of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and
CXCL7/neutrophil activating peptide 2 by DLD1 cells (p < 0.05 compared with control). Among
these mediators, the production of BMP4 was
greatly reduced; therefore, we further investigated
the role of BMP4, a member of the transforming
growth factor beta (TGF-b) superfamily, in the
CamB-inhibited metastatic power by exploring the
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Fig. 2. Low-doses CamB inhibit migration, invasion, and adhesion of CRC cells and disrupt cytoskeleton organization. Cells were treated with
CamB at indicated concentrations for 24 h, and then subjected to (A) transmigration and invasion assay, (B) cell adhesion assay, (C) colony formation assay,
and (D) cytoskeleton structure assay using immunoﬂuorescence staining and confocal microscopy (200). F-actin is shown as red. Nuclei are shown as blue
by DAPI staining. Quantitative results are presented as mean ± SD. * and **, p < 0.01 and p < 0.001 compared with control, respectively.

effects of CamB on important signaling components
associated with cancer metastasis. Our results
showed that CamB dose-dependently reduced the
protein and mRNA expression of BMP4 (Fig. 3C and
D), inhibited the BMP4 canonical Smad signaling,
and suppressed focal adhesion cascade, including
FAK/Src/paxillin axis (Fig. 3EeH), and small
GTPase Rho/Cdc42/Rac activation (Fig. 3I and J) in
DLD-1 and SW480 cells. Collectively, these ﬁndings
reveal that CamB can regulate the production of
cytokines and signaling pathways that were strongly
associated with the metastatic power of CRC cells.
3.4. BMP4 restores the metastatic power of CRC
cells and the Smad/FAK signaling reduced by
CamB
Next, we analyzed the effects of BMP4 on the
metastatic potentials of DLD-1 and SW480 cells to

further explore the involvement of BMP4 in the inhibition of metastatic potential by CamB. As shown
in Fig. 4A and B, BMP4 treatments promoted the cell
adhesion and colony formation capabilities of DLD1 and SW480 cells (p < 0.05 compared with control).
Similarly, the migratory and invasive capacities of
both cell lines were also enhanced by BMP4 treatment (Fig. 4C and D, p < 0.05 compared with control). Likewise, BMP4 signiﬁcantly restored the
metastatic potentials that were reduced by CamB
(Fig. 4EeH, p < 0.05 compared with CamB treatment
alone). We also observed by confocal microscopy
analysis that BMP4 clearly induced the spread of
cytoskeleton and resulted in the expansion of cell
shape, which were inhibited by CamB (Fig. 4I).
Then, we investigated the effects of BMP4 on CamBmediated Smad and FAK cascades in DLD-1 and
SW480 cells. Our results showed that BMP4 alone
slightly induced the phosphorylation of Smad1/5/9,
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Fig. 3. CamB downregulates BMP4 and inhibited FAK signaling and Rho A small GTPase activation in CRC cells. (AeD) Cells were treated
with 30 mM CamB for 24 h, washed with PBS and incubated with serum-free medium for 24 h, then the culture medium was collected for human
cytokine array, and the cells were harvested for Western blot and qPCR analysis. (A) Representative array image for cytokine production by DLD1 cells. (B) Quantitative results of array analysis; (C, D) Protein and mRNA expression of BMP4 in DLD-1 cells. (EeJ) Cells were treated with 30 mM
CamB for 24 h, and then lysed for Western blot and GTPase activity assay. (E) Phosphorylation and expression of Smads in total and nucleus
fraction; (F) Expression of integrin-associated signaling components; (G) Activation of FAK-associated signaling components; (H) Phosphorylation of
paxillin; (I) Protein level of small GTPases; (J) GTPase afﬁnity precipitation followed Western blot. b-actin and tubulin were used as the internal
controls. Quantitative results are presented as mean ± SD. * and **, p < 0.01 and p < 0.001 compared with the control, respectively.

FAK(Y937), Src(Y416), and paxillin (Y118/Y181/Y31),
as well as restored the phosphorylation of these
Smad/FAK signaling components inhibited by
CamB (Fig. 4J and K). Simialrly, BMP4 also restored
the protein expression of RhoA, Cdc42, and Rac1
inhibited by CamB in DLD-1 and SW480 cells
(Fig. 4). Collectively, these ﬁndings indicate that
BMP4 can restore the metastatic power of CRC cells
and the Smad/FAK and Rho/Cdc42/Rac signaling
cascade inhibited by CamB in CRC cells. Thus,

BMP4 plays an important role in the inhibitory effect of CamB on the metastatic power of CRC cells.
3.5. CamB downregulates BMP4 expression by
promoting ubiquitin-mediated Snail protein
degradation
Epithelialemesenchymal
transition
(EMT)
inducer Snail is a transcription factor that plays
pivotal roles in reinforcing the metastatic potential
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Fig. 4. Involvement of BMP4 in CamB-inhibited metastatic potential and signaling cascade in colon cancer cells. (AeD) Cells were treated
with recombinant BMP4 (50 ng/mL) for 24 h and then subjected to (A) Cell adhesion assay, (B) Colony formation assay, (C) Migration assay, and (D)
Invasion assay. (EeL) Cells were pretreated without or with recombinant BMP4 (50 ng/mL) for 2 h, then treated with 30 mM CamB for 24 h, and
subjected to (E) Cell adhesion assay; (F) Colony formation assay; (G) Migration assay; (H) Invasion assay; (I) Immunoﬂuorescence assay for F-actin
(red); and (JeL) Western blot for the phosphorylation and expression of (J) Smad, FAK, and Src; (K) paxillin; and (L) Rho small GTPases. Nuclei
(blue) were detected by DAPI staining. Tubulin was used as the internal control. Quantitative results are presented as mean ± SD. * and **, p < 0.01
and p < 0.001 compared with the control, respectively.

of CRC cells through the regulation of cell motility,
invasiveness, and cell adhesion [9]. Next, we
explored the mechanism by which CamB inhibited
BMP4 transcription in CRC cells and the link between Snail and BMP4. As shown in Fig. 5A and B,
CamB inhibited Snail protein expression and
reduced Snail in the nucleus of DLD-1 and
SW480 cells. To further explore whether Snail
regulate BMP4 transcription, BMP4 promoter region
(Gene ID: LOC109433677) were used for searching
putative Snail binding motif, and the results showed
that the proximal promoter of the BMP4 gene
included a putative E-box binding motif CANNTG
for Snail (data not shown). Then, we demonstrated
by chromatin immunoprecipitation and reporter
assay that Snail directly bound to the putative E-box
on BMP4 promoter and CamB was able to inhibit
the transcriptional activity induced by BMP4 promoter (Fig. 5C and D). We also overexpressed Snail
in DLD-1 and SW480 cells by transfecting Snailexpressing vectors and similarly observed that
CamB inhibited the binding of Snail to BMP4 promoter (Fig. 5E). Further investigation showed that
CamB did not alter mRNA expression of Snail
(Fig. 5F), and pretreatment of cycloheximide, a
protein synthesis inhibitor, promoted the downregulation of Snail in response to CamB (Fig. 5G).
Meanwhile, pretreatment of MG132, a proteasome
inhibitor, restored the downregulation and ubiquitination of Snail in response to CamB (Fig. 5H and
I). Collectively, these results indicate that Snail plays

an important role in BMP4 expression, and CamB
promotes the ubiquitin-mediated protein degradation of Snail and therefore inhibits the transcription
of BMP4.
3.6. CamB inhibits the in vivo metastasis of DLD1 cells and downregulates BMP4 and Snail
expression in DLD-1-derived tumor
We demonstrated the in vivo effect of CamB on
the metastasis of CRC cells using a xenograft mouse
model. As shown in Fig. 6A, the oral administration
of CamB (10 and 20 mg/kg) clearly reduced the
metastasis of Luc-DLD-1 cells in the liver and
abdomen using an in vivo imaging system (Fig. 6A).
We observed that CamB alone did not inﬂuence the
phenotype of spleen, liver, and colon tissues
compared with the control group. Meanwhile,
CamB clearly reduced the Luc-DLD-1 cells that
grew in the spleen and colon and those that
metastasized to the liver of xenograft mice (Fig. 6B
and C). Further IHC staining analysis showed that
the Luc-DLD-1 cells that transferred to the liver
highly expressed BMP4 and Snail, and CamB
administration remarkably reduced the BMP4 and
Snail expression of Luc-DLD-1 cells in the liver
(Fig. 6D and E). Taken together, these observations
reveal that CamB administration inhibits the in vivo
metastasis of DLD-1 colon cancer cells into the liver,
colon, and spleen, and this inhibition is associated
with the decreased expression of BMP4 and Snail.
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Fig. 5. CamB reduced Snail protein stability and its binding to the BMP4 promoter via promoting ubiquitin-proteasome degradation in
CRC cells. (A) Cells were treated with 30 mM CamB for 24 h, and the protein levels of Snail (green) and F-actin (red) were detected by immunoﬂuorescence staining and confocal microscopy (scale bars, 10 mm). (B) Cells were treated with the indicated CamB concentrations for 24 h, and then
lysed for the immunodetection of Snail. (C) Cells were treated with 30 mM CamB for 24 h, and then subjected to chromatin immunoprecipitation using
anti-Snail antibody and RT-PCR using BMP4-speciﬁc primer, Input: total native chromatin, IgG: isotype control, NTC: no template control. (D) Cells
were transfected with BMP4 promoter-vector and treated with the indicated CamB concentrations for 24 h, and then luciferase activity was analyzed
by reporter assay. (E) Cells were transiently transfected with Snail-expressing vector and treated with 30 mM CamB for 24 h, and the binding of Snail
to BMP4 promoter was determined by chromatin immunoprecipitation. (F) Cells were incubated with 30 mM CamB for 24h and lysed for mRNA
extraction and qPCR analysis. (G, H) Cells were pretreated with MG132 or cytoheximide for 6 h, treated with 30 mM CamB for 24 h, and lysed for the
immunodetection of Snail. (I) Cells were pretreated with MG132 for 6 h, treated with 30 mM CamB for 24 h, and lysed for immunoprecipitation by
anti-Snail and immunoblotting by anti-ubiquitin and anti-Snail antibodies. Quantitative results were acquired by densitometric analysis and are
presented as mean ± SD. * and **, p < 0.01 and p < 0.001 compared with control, respectively.

4. Discussion
BMPs belong to the TGF-b superfamily, which
were originally identiﬁed as osteo-inductive cytokines and have the effect of promoting bone and
cartilage formation [14,15]. Recently, BMP4 plays

critical roles in cancer progression and tumor
metastasis via Smad signaling [16,17]. Our ﬁndings
reveal that BMP4 stimuli remarkably enhance the
cell adhesion, colony formation, cell motility, and
invasion of CRC cells, and CamB co-treatment diminishes these BMP4-induced tumorigenicity. In

Fig. 6. CamB administration in vivo inhibited CRC cell metastasis and reduced BMP4 and Snail expression in xenograft mice. Mice received
Lu-DLD-1 cells via splenic or intraperitoneal injection, and then CamB (10 and 20 mg/kg) were orally administrated every 5 days. After 35 days of
CamB administration, the mice were subjected to (A) Bioluminescent imaging analysis for luciferase activity and then sacriﬁced for the assessment of
(B) metastatic lesion phenotype and tissue weights, (C) tumor metastasis by H&E staining, and (D, E) BMP4 and Snail level detection in liver
metastatic lesion by IHC staining. Quantitative results are presented as mean ± SD. * and **, p < 0.01 and p < 0.001 compared with the control
group, respectively.

the canonical pathway, BMP4 binds to type I and II
serine/threonine kinase receptors to form a complex, which triggers the phosphorylation of Smad1/
5/9, and the phosphorylated Smad1/5/9 binds to
Smad4 and translocates to the nucleus to exert gene
regulation activity [18]. Our results show that CamB
treatment decreased the phosphorylation of Smad1/
5/9 and reduced nuclear Smad4 in DLD-1 cells. The
results suggest that BMP4 plays an important role in
promoting the metastatic capability of CRC cells
and CamB can attenuate the metastatic capability of
CRC cells via the inhibition of the BMP4/Smad
cascade.
FAK signaling axis plays a pivotal role in controlling actin cytoskeleton remodeling, cell adhesion, and cell migration, which are involved in
tumor metastasis [9,19]. In addition, FAK and BMP4induced mesenchymal stem cell adipogenesis are
linked together [20]. Interestingly, our observations
showed that although the protein expression of the
FAK axis, including FAK, talin, tensin 2, a-actinin,
and vinculin, was not remarkably altered, CamB
clearly suppressed the phosphorylation of FAK, Src,
paxillin, and Akt. In addition, CamB also reduced
the protein level and enzyme activity of small
GTPases associated with FAK signaling, including
Rho A, Cdc42, and Rac-1. In conclusion, these
ﬁndings revealed that CamB treatment reduced
BMP4 and its downstream signaling activation.
The induction of EMT is highly related to the
progression and metastasis of CRC, and early and
invasive metastasis is often the main cause of death
in patients with CRC. Dynamic changes in cytoskeletal assembly during EMT leads to the loss of
cellecell contact and polarity in epithelial cells with
enhanced cell motility. Thus, potent EMT inducers,
such as Snail, Slug, and Twist, have been implicated
in tumor progression and metastasis [21,22]. Our
observations showed that Snail bound to the promotor of BMP4 and CamB clearly reduced Snail
protein level and BMP4 transcription by increasing
the ubiquitin-mediated degradation of Snail. Thus,
CamB attenuates BMP4-induced metastatic potentials and inhibits the Snail-mediated EMT of CRC
cells.
In conclusion, our ﬁndings demonstrated that
CamB clearly attenuates the metastatic potential of
CRC cells and inhibits the metastasis of CRC cells in
xenograft mice through the suppression of BMP4mediated Smad/FAK axis by promoting the ubiquitin-proteasome degradation of Snail. Collectively,
the results suggest that CamB may be an effective
adjuvant for CRC treatments, and BMP4 may be a
potential molecular target for the development of
anti-CRC drugs.
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